Healthcare

Key takeawaysCEO Gordon Naylor bought 1,100 CSL shares for $107,800 via an on-market purchase.Shares are down more than 23 per cent over the past month following anEarningsdowngrade.Investor focus remains on the trajectory of margins, IGFranchiseand plasma collection costs.Long-term plasmaDemandremains a structural positive for theBusiness.Sentiment …

HealthCo Healthcare & Wellness REIT (ASX:HCW) has provided an update on the ongoing restructuring of its Healthscope hospital portfolio, confirming a key milestone in the transition of The Mount Private Hospital in Western Australia to a new long-term operator.

Acrux Ltd (ASX:ACR) shares surged during afternoon trade on 28 May 2026 after the specialty pharmaceutical company announced an expanded licensing agreement for its menopause hormone therapy product Lenzetto in the Australian market.

Actinogen Medical Ltd (ASX:ACW) shares rose during morning trade on 28 May 2026 after the biotechnology company announced favourable feedback from the European Medicines Agency (EMA) regarding its Alzheimer’s disease development program for Xanamem.

Emyria Limited (ASX:EMD) shares moved 2.5% higher to AUD 0.041 during the morning session on 28 May 2026 after the company welcomed aTherapeutic Goods Administration(TGA) update relating to psychedelic-assisted psychotherapy (PAT) under the Authorised Prescriber (AP) scheme.

Imugene Limited (ASX:IMU) shares edged higher during morning trade on 28 May 2026 after the clinical-stage immuno-oncology company announced the first patient had been dosed in the Bruton Tyrosine Kinase inhibitor (BTKi) combination cohort of its ongoing Phase 1b azer-cel study.

Acrux Ltd (ASX:ACR) ended the latestTrading sessionunchanged at A$0.010 on 27 May 2026, reflecting a subdued day of price action for the micro-cap pharmaceutical stock. While the share price showed no movement, the stock remains on investor watchlists due to its positioning within the …